| Table of contents |
Table of Contents
SUMMARY TABLE OF SURVEY IMPLEMENTATION AND THE SURVEY POPULATION, NICS, 2016/17 III
SUMMARY TABLE OF FINDINGS: NICS, 2016/17 ........................................................................... IV
TABLE OF CONTENTS .................................................................................................................... V
LIST OF TABLES .......................................................................................................................... VII
LIST OF FIGURES ........................................................................................................................ VIII
ACKNOWLEDGEMENT ................................................................................................................. IX
EXECUTIVE SUMMARY ................................................................................................................. X
LIST OF ABBREVIATIONS ............................................................................................................. XII
I.
INTRODUCTION....................................................................................................................................................... 1
COUNTRY CONTEXT NIGERIA ................................................................................................................................. ..... 1
BACKGROUND TO THE VACCINATION PROGRAM ................................................................................................................ 2
NATIONAL IMMUNISATION PROGRAM STRATEGIC PLAN........................................................................................................ 3
SURVEY OBJECTIVES .................................................................................................................................................. 5
II.
SAMPLE AND SURVEY METHODOLOGY............................................................................................................................... 6
SAMPLE DESIGN ........................................................................................................................................................ 6
QUESTIONNAIRES ...................................................................................................................................................... 7
TRAINING AND FIELDWORK .......................................................................................................................................... 8
SURVEY ORGANISATION .............................................................................................................................................. 9
SURVEY CONSTRAINTS ................................................................................................................................................11
III. ............. SAMPLE COVERAGE AND THE CHARACTERISTICS OF HOUSEHOLDS AND RESPONDENTS...........................................................................................................................................................12
SAMPLE COVERAGE .....................................................................................................................................................12
CHARACTERISTICS OF HOUSEHOLDS ................................................................................................................................15
HOUSING CHARACTERISTICS, ASSET OWNERSHIP, AND WEALTH QUINTILES ................................................................................21
VI.
VACCINATION COVERAGE.............................................................................................................................................. 26
IMMUNISATION COVERAGE OF ALL ANTIGENS: FULL IMMUNISATION COVERAGE (CARD AND RECALL) ...................................................26
BCG COVERAGE ...........................................................................................................................................................29
BCG SCAR...................................................................................................................................................................30
HEPATITIS B AT BIRTH ...................................................................................................................................................33
POLIO ........................................................................................................................................................................33
POLIO AT BIRTH ...........................................................................................................................................................33
ORAL POLIO VIRUS VACCINE ............................................................................................................................................33
PENTAVALENT VACCINE ..................................................................................................................................................36
YELLOW FEVER VACCINE .................................................................................................................................................40
MEASLES VACCINE .........................................................................................................................................................40
NONE (NOT VACCINATED) ................................................................................................................................................43
VITAMIN A ...................................................................................................................................................................43
AVAILABILITY OF HOME-BASED VACCINATION RECORDS ...........................................................................................................43
V. SERVICE QUALITY AND IMMUNISATION SYSTEM UTILIZATION (DROPOUT RATE) ........................................................................... 44
VACCINATION DROPOUT ..................................................................................................................................................44
PENTAVALENT 1 - PENTAVALENT 3 DROPOUT ..........................................................................................................................47
PENTAVALENT 1 - MEASLES DROPOUT ...................................................................................................................................47
VALID COVERAGE ............................................................................................................................................................48
TIMELINESS OF VACCINATIONS ...........................................................................................................................................53
PENTAVALENT 1 DOSES GIVEN BEFORE SIX WEEKS OF AGE ...........................................................................................................55
INTERVAL OF PENTAVALENT VACCINES ADMINISTRATION SHORTER THAN 28 DAYS .............................................................................55
MEASLES DOSES GIVEN BEFORE NINE MONTHS OF AGE................................................................................................................55
MISSED OPPORTUNITIES FOR VACCINATION ............................................................................................................................55
REASONS FOR NON-VACCINATION ........................................................................................................................................59
PLACE OF VACCINATION .....................................................................................................................................................60
APPENDIX A.
SAMPLE DESIGN - MICS....................................................................................................................................................... 62
SAMPLE SIZE CONSIDERATION FOR MICS..................................................................................................................................62
SAMPLE SIZE AND SAMPLE ALLOCATION ...................................................................................................................................62
SAMPLING FRAME AND SELECTION OF CLUSTERS ........................................................................................................................63
LISTING ACTIVITIES ...........................................................................................................................................................63
SELECTION OF HOUSEHOLDS .................................................................................................................................................63
CALCULATION OF SAMPLE WEIGHTS ........................................................................................................................................63
APPENDIX A.1: SAMPLE DESIGN- SUPPLEMENTAL SAMPLING & POOLABILITY TESTING ............................................................................ 66
SAMPLE FOR THE NIGERIA NATIONAL IMMUNISATION COVERAGE SURVEY (NICS) ..................................................................................66
APPENDIX B.
ANNEX TABLES................................................................................................................................................................... 71
APPENDIX C.
LIST OF PERSONNEL INVOLVED IN THE SURVEY............................................................................................................................ 86
APPENDIX D.
NIGERIA 2016/17 NICS QUESTIONNAIRES................................................................................................................................. 102
List of Tables
TABLE HH. 1: RESULTS OF HOUSEHOLD AND CHILDREN 12 TO 23 MONTHS RESPONSE RATES ....................................................................12
TABLE HH. 2: RESULTS OF HOUSEHOLD AND CHILDREN 12 TO 23 MONTHS RESPONSE RATES BY STATE.........................................................13
TABLE HH. 3: NUMBER OF INACCESSIBLE ENUMERATION AREAS BY STATE ...........................................................................................14
TABLE HH. 4: AGE DISTRIBUTION OF HOUSEHOLD POPULATION BY SEX ...............................................................................................15
TABLE HH. 5: HOUSEHOLD COMPOSITION ...................................................................................................................................17
TABLE HH. 6: HOUSEHOLD COMPOSITION (CONTINUED) ..................................................................................................................18
TABLE HH. 7: HOUSING CHARACTERISTICS .................................................................................................................................22
TABLE HH. 8: HOUSEHOLD AND PERSONAL ASSETS ........................................................................................................................23
TABLE HH. 9: WEALTH QUINTILES..............................................................................................................................................24
TABLE IM. 1: ESTIMATED % OF CHILDREN 12-23 MONTHS WITH ANY EVIDENCE OF VACCINATION, NIGERIA COMBINED MICS/NICS, 2016-17 ..................................................................................27
TABLE IM. 2: ESTIMATED % OF CHILDREN 12-23 MONTHS WITH ANY EVIDENCE OF VACCINATION, NIGERIA COMBINED MICS/NICS, 2016-17 (CONTINUED) ................................................................28
TABLE IM. 3: ESTIMATED % OF CHILDREN 12-23 MONTHS WITH ANY EVIDENCE OF VACCINATION BCG AND HEPATITIS B AT BIRTH, NIGERIA COMBINED MICS/NICS, 2016-17 ..........................................31
TABLE IM. 4: ESTIMATED % OF CHILDREN 12-23 MONTHS WITH ANY EVIDENCE OF VACCINATION BCG AND HEPATITIS B AT BIRTH,, NIGERIA COMBINED MICS/NICS, 2016-17 (CONTINUED) .......................32
TABLE IM. 5: ESTIMATED % OF CHILDREN 12-23 MONTHS WITH ANY EVIDENCE OF VACCINATION, NIGERIA COMBINED MICS/NICS, 2016-17 ..................................................................................35
TABLE IM. 6: ESTIMATED % OF CHILDREN 12-23 MONTHS WITH ANY EVIDENCE OF VACCINATION, NIGERIA COMBINED MICS/NICS, 2016-17 (CONTINUED) .................................................................36
TABLE IM. 7: ESTIMATED % OF CHILDREN 12-23 MONTHS WITH ANY EVIDENCE OF VACCINATION, NIGERIA COMBINED MICS/NICS, 2016-17 ..................................................................................38
TABLE IM. 8: ESTIMATED % OF CHILDREN 12-23 MONTHS WITH ANY EVIDENCE OF VACCINATION, NIGERIA COMBINED MICS/NICS, 2016-17 (CONTINUED) .................................................................39
TABLE IM. 9: ESTIMATED % OF CHILDREN 12-23 MONTHS WITH ANY EVIDENCE OF VACCINATION - MEASLES AND YELLOW FEVER, NIGERIA COMBINED MICS/NICS, 2016-17 ............................................41
TABLE IM. 10: ESTIMATED % OF CHILDREN 12-23 MONTHS WITH ANY EVIDENCE OF VACCINATION MEASLES AND YELLOW FEVER, NIGERIA COMBINED MICS/NICS, 2016-17 (CONTINUED) ...........................42
TABLE IM. 11: ESTIMATED % OF CHILDREN 12-23 MONTHS WHO RECEIVED FIRST DOSE IN A MULTI-DOSE SEQUENCE BUT FAILED TO RECEIVE THE FINAL DOSE, NIGERIA COMBINED MICS/NICS, 2016 ...........44
TABLE IM. 12: ESTIMATED % OF CHILDREN 12-23 MONTHS WHO RECEIVED FIRST DOSE IN A MULTI-DOSE SEQUENCE BUT FAILED TO RECEIVE THE FINAL DOSE, NIGERIA COMBINED MICS/NICS, 2016 (CONTINUED) .............................................................................................................................................................................................................................................45
TABLE IM. 13: ESTIMATED % OF CHILDREN 12-23 MONTHS WITH EVIDENCE OF VALID DOSE VACCINATION, NIGERIA COMBINED MICS/NICS, 2016 ...........................................................................50
TABLE IM. 14: ESTIMATED % OF CHILDREN 12-23 MONTHS WITH EVIDENCE OF VALID DOSE VACCINATION, NIGERIA COMBINED MICS/NICS, 2016 (CONTINUED) ..........................................................51
TABLE IM. 15: TIMELINESS OF VACCINATION FOR CHILDREN 12-23 MONTHS, NIGERIA COMBINED MICS/NICS, 2016 .................................................................................................................53
TABLE IM. 16: TIMELINESS OF VACCINATION FOR CHILDREN 12-23 MONTHS, NIGERIA COMBINED MICS/NICS, 2016 (CONTINUED) ................................................................................................54
TABLE IM. 17: MISSED OPPORTUNITIES FOR SIMULTANEOUS VACCINATION (MOV), NIGERIA COMBINED MICS/NICS, 2016 ..........................................................................................................57
TABLE IM. 18: MISSED OPPORTUNITIES FOR SIMULTANEOUS VACCINATION (MOV), NIGERIA COMBINED MICS/NICS, 2016 (CONTINUED) ........................................................................................58
TABLE IM. 21: PLACES CHILDREN RECEIVE VACCINES, NIGERIA COMBINED MICS/NICS, 2016 .............................................................................................................................................60
TABLE IM. 22: PLACES CHILDREN RECEIVE VACCINES, NIGERIA COMBINED MICS/NICS, 2016 (CONTINUED) ............................................................................................................................61
List of Figures
FIGURE 1: MAP OF NIGERIA SHOWING STATE BOUNDARIES ...................................................................................................................................................................................... 2
FIGURE 2: MAP SHOWING SELECTION OF SUPPLEMENTAL ENUMERATION AREAS ............................................................................................................................................................. 6
FIGURE 3: NICS ORGANISATIONAL AND OPERATIONAL STRUCTURE ............................................................................................................................................................................10
FIGURE 4: AGE AND SEX DISTRIBUTION OF HOUSEHOLD POPULATION, NIGERIA NICS, 2016/17 ..........................................................................................................................................16
FIGURE 5: SHOWING STATE AND NATIONAL PROPORTION OF CHILDREN FULLY IMMUNISED ...............................................................................................................................................26
FIGURE 6: MAP SHOWING THE PERCENTAGE OF CHILDREN 12 TO 23 MONTHS FULLY VACCINATED BY STATE ...........................................................................................................................29
FIGURE 8: PENTAVALENT 3 VACCINE COVERAGE BY STATE .......................................................................................................................................................................................37
FIGURE 11: DROPOUT BETWEEN PENTAVALENT 1 AND PENTAVALENT 3 ........................................................................................................................................................................46
FIGURE 12: SHOWING DROPOUT BETWEEN PENTAVALENT 1 VACCINE AND PENTAVALENT 3 VACCINE ....................................................................................................................................47
FIGURE 13: SHOWING DROPOUT BETWEEN PENTAVALENT 1 VACCINE AND MEASLES ........................................................................................................................................................48
FIGURE 16: REASONS FOR NON-VACCINATION - PERCENTAGE ..................................................................................................................................................................................59 |
